Description
What is ravulizumab-cwvz used for?
Ultomiris, is a humanized monoclonal antibody complement inhibitor medication designed for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. It is designed to bind to and prevent the activation of Complement component 5 (C5).
What is the brand name under which ravulizumab-cwvz is sold?
Ravulizumab-cwvz, sold under the brand name ULTOMIRIS among others. Call IPN, Delhi to get access in India.
Is the brand name for ravulizumab-cwvz is available in India?
Yes, the brand name for ravulizumab-cwvz available in India with IPN, Delhi on request.
Get Access to ULTOMIRIS (ravulizumab-cwvz) In India
Medvitaz Pharma is equipped to facilitate the distribution of ULTOMIRIS (ravulizumab-cwvz) (prescription medications) worldwide and throughout India upon completion of necessary legal procedures, if applicable.
To inquire about the price of either the branded medication “ULTOMIRIS (ravulizumab-cwvz)” or the generic version “ravulizumab-cwvz” for personal use under patient-specific treatment in various cities including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, and others in India, please fill out the request form. Upon receiving your request and assessing the delivery process, we will provide you with an estimated price for the medication within 24 hours.
For any inquiries or assistance, please reach out to our Patient Support Team. We are available to assist you from Monday to Friday, between 9:00 and 19:00 IST. You can contact us via email at [email protected], toll-free at +91 8750295029, or through WhatsApp at +91-8750295029.